These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

678 related items for PubMed ID: 15534358

  • 1. Autologous and allogeneic stem-cell transplantation as salvage treatment of acute promyelocytic leukemia initially treated with all-trans-retinoic acid: a retrospective analysis of the European acute promyelocytic leukemia group.
    de Botton S, Fawaz A, Chevret S, Dombret H, Thomas X, Sanz M, Guerci A, San Miguel J, de la Serna J, Stoppa AM, Reman O, Stamatoulas A, Fey M, Cahn JY, Sotto JJ, Bourhis JH, Parry A, Chomienne C, Degos L, Fenaux P.
    J Clin Oncol; 2005 Jan 01; 23(1):120-6. PubMed ID: 15534358
    [Abstract] [Full Text] [Related]

  • 2. Arsenic trioxide therapy for relapsed acute promyelocytic leukemia: a bridge to transplantation.
    Leoni F, Gianfaldoni G, Annunziata M, Fanci R, Ciolli S, Nozzoli C, Ferrara F.
    Haematologica; 2002 May 01; 87(5):485-9. PubMed ID: 12010661
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Hematopoietic stem cell transplantation in the second or later complete remission in acute promyelocytic leukemia initially treated with all-trans retinoic acid].
    Fujita H, Nakaya A, Kato J, Tachibana T, Takemura S, Hyo R, Kawano T, Tanaka M, Taguchi J, Maruta A, Fujimaki K, Kanamori H, Ishigatsubo Y.
    Rinsho Ketsueki; 2005 Oct 01; 46(10):1095-9. PubMed ID: 16440769
    [Abstract] [Full Text] [Related]

  • 5. Long-term survival and prognostic study in acute promyelocytic leukemia treated with all-trans-retinoic acid, chemotherapy, and As2O3: an experience of 120 patients at a single institution.
    Hu J, Shen ZX, Sun GL, Chen SJ, Wang ZY, Chen Z.
    Int J Hematol; 1999 Dec 01; 70(4):248-60. PubMed ID: 10643151
    [Abstract] [Full Text] [Related]

  • 6. Management of acute promyelocytic leukemia relapse in the ATRA era.
    Castagnola C, Lunghi M, Corso A, Tajana M, Zappasodi P, Dabusti M, Lazzarino M, Bernasconi C.
    Haematologica; 1998 Aug 01; 83(8):714-7. PubMed ID: 9793255
    [Abstract] [Full Text] [Related]

  • 7. [Effect of all-trans retinoic acid on the newly diagnosed acute promyelocytic leukaemia: our experience].
    Rolovitsh Z, Cholovitsh M, Elezovitsh I, Vidovitsh A, Radoshevitsh-Radojkovitsh N, Boshkovitsh D, Novak A, Basara N.
    Srp Arh Celok Lek; 1995 Aug 01; 123(11-12):279-85. PubMed ID: 16296239
    [Abstract] [Full Text] [Related]

  • 8. Toward optimization of postremission therapy for residual disease-positive patients with acute myeloid leukemia.
    Maurillo L, Buccisano F, Del Principe MI, Del Poeta G, Spagnoli A, Panetta P, Ammatuna E, Neri B, Ottaviani L, Sarlo C, Venditti D, Quaresima M, Cerretti R, Rizzo M, de Fabritiis P, Lo Coco F, Arcese W, Amadori S, Venditti A.
    J Clin Oncol; 2008 Oct 20; 26(30):4944-51. PubMed ID: 18606980
    [Abstract] [Full Text] [Related]

  • 9. Comparison of intensive chemotherapy, allogeneic or autologous stem cell transplantation as post-remission treatment for adult patients with high-risk acute lymphoblastic leukemia. Results of the PETHEMA ALL-93 trial.
    Ribera JM, Oriol A, Bethencourt C, Parody R, Hernández-Rivas JM, Moreno MJ, del Potro E, Torm M, Rivas C, Besalduch J, Sanz MA, Ortega JJ, PETHEMA Group, Spain.
    Haematologica; 2005 Oct 20; 90(10):1346-56. PubMed ID: 16219571
    [Abstract] [Full Text] [Related]

  • 10. Results of risk-adapted therapy in acute myeloid leukaemia. A long-term population-based follow-up study.
    Wahlin A, Billström R, Björ O, Ahlgren T, Hedenus M, Höglund M, Lindmark A, Markevärn B, Nilsson B, Sallerfors B, Brune M.
    Eur J Haematol; 2009 Aug 20; 83(2):99-107. PubMed ID: 19385987
    [Abstract] [Full Text] [Related]

  • 11. Outcome of acute promyelocytic leukemia (APL) in children and adolescents: an analysis in two consecutive trials of the European APL Group.
    Bally C, Fadlallah J, Leverger G, Bertrand Y, Robert A, Baruchel A, Guerci A, Recher C, Raffoux E, Thomas X, Leblanc T, Idres N, Cassinat B, Vey N, Chomienne C, Dombret H, Sanz M, Fenaux P, Adès L.
    J Clin Oncol; 2012 May 10; 30(14):1641-6. PubMed ID: 22473162
    [Abstract] [Full Text] [Related]

  • 12. Clinico-biological features and outcome of acute promyelocytic leukemia patients with persistent polymerase chain reaction-detectable disease after the AIDA front-line induction and consolidation therapy.
    Breccia M, Diverio D, Noguera NI, Visani G, Santoro A, Locatelli F, Damiani D, Marmont F, Vignetti M, Petti MC, Lo Coco F.
    Haematologica; 2004 Jan 10; 89(1):29-33. PubMed ID: 14754603
    [Abstract] [Full Text] [Related]

  • 13. The role of bone marrow transplantation in acute promyelocytic leukemia.
    Nabhan C, Mehta J, Tallman MS.
    Bone Marrow Transplant; 2001 Aug 10; 28(3):219-26. PubMed ID: 11535988
    [Abstract] [Full Text] [Related]

  • 14. Early stem cell transplantation for refractory acute leukemia after salvage therapy with high-dose etoposide and cyclophosphamide.
    Johny A, Song KW, Nantel SH, Lavoie JC, Toze CL, Hogge DE, Forrest DL, Sutherland HJ, Le A, Nitta JY, Barnett MJ, Smith CA, Shepherd JD, Nevill TJ.
    Biol Blood Marrow Transplant; 2006 Apr 10; 12(4):480-9. PubMed ID: 16545732
    [Abstract] [Full Text] [Related]

  • 15. Repetitive cycles of high-dose cytarabine are effective for childhood acute myeloid leukemia: long-term outcome of the children with AML treated on two consecutive trials of Tokyo Children's Cancer Study Group.
    Tomizawa D, Tabuchi K, Kinoshita A, Hanada R, Kigasawa H, Tsukimoto I, Tsuchida M, Tokyo Children's Cancer Study Group.
    Pediatr Blood Cancer; 2007 Aug 10; 49(2):127-32. PubMed ID: 16807916
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Autologous stem cell transplantation for patients with acute promyelocytic leukemia in second molecular remission.
    Ferrara F, Finizio O, Izzo T, Riccardi C, Criscuolo C, Carbone A, Borlenghi E, Rossi G.
    Anticancer Res; 2010 Sep 10; 30(9):3845-9. PubMed ID: 20944181
    [Abstract] [Full Text] [Related]

  • 18. All-trans retinoic acid (ATRA) in the treatment of acute promyelocytic leukemia (APL).
    Chim CS, Kwong YL, Liang R, Chu YC, Chan CH, Chan LC, Wong KF, Chan TK.
    Hematol Oncol; 1996 Sep 10; 14(3):147-54. PubMed ID: 9119359
    [Abstract] [Full Text] [Related]

  • 19. Comparison of allogeneic stem cell transplantation, high-dose cytarabine, and autologous peripheral stem cell transplantation as postremission treatment in patients with de novo acute myelogenous leukemia.
    Tsimberidou AM, Stavroyianni N, Viniou N, Papaioannou M, Tiniakou M, Marinakis T, Skandali A, Sakellari I, Yataganas X, Hellenic Cooperative Group.
    Cancer; 2003 Apr 01; 97(7):1721-31. PubMed ID: 12655529
    [Abstract] [Full Text] [Related]

  • 20. Outcome of patients with acute promyelocytic leukemia failing to front-line treatment with all-trans retinoic acid and anthracycline-based chemotherapy (PETHEMA protocols LPA96 and LPA99): benefit of an early intervention.
    Esteve J, Escoda L, Martín G, Rubio V, Díaz-Mediavilla J, González M, Rivas C, Alvarez C, González San Miguel JD, Brunet S, Tomás JF, Tormo M, Sayas MJ, Sánchez Godoy P, Colomer D, Bolufer P, Sanz MA, Spanish Cooperative Group PETHEMA.
    Leukemia; 2007 Mar 01; 21(3):446-52. PubMed ID: 17205057
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.